Bain, Pfizer launch biotech startup to tackle brain disorders

For Pfizer, the announcement marks a return, of sorts, to the challenging field of neuroscience.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.